Stock comparison
Lam Research
Synopsys
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
LRCX
Lam Research
Market cap
$385.48B
Sector
Technology
SNPS
Synopsys
Market cap
$100.52B
Sector
Technology
Overall winner
Lam Research LRCX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | LRCX | SNPS | Winner |
|---|---|---|---|
| Warren Buffett | 78B | 57C | LRCX |
| Benjamin Graham | 88A | 70B | LRCX |
| Philip Fisher | 76B | 72B | LRCX |
| Peter Lynch | 69B | 69B | Tie |
| Joel Greenblatt | 84C | 46D | LRCX |
| Charlie Munger | 86A | 61C | LRCX |
| Terry Smith | 88A | 59D | LRCX |
Side-by-side metrics
| Metric | LRCX | SNPS |
|---|---|---|
| Market cap | $385.48B | $100.52B |
| P/E (TTM) | 55.4x | 73.1x |
| EV/EBIT | 62.9x | 113.8x |
| ROIC (TTM) | 42.79% | 1.97% |
| Gross margin | 49.98% | 75.14% |
| Net margin | 30.94% | 13.75% |
| Revenue CAGR 5y | 5.96% | 13.81% |
| EPS CAGR 5y | 11.27% | 13.15% |
| Debt / Equity | 0.4x | 0.3x |
| Dividend yield | 0.34% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
LRCX leads on
- Dividend yield0.34%vs 0.0%+100%
- ROIC (TTM)42.79%vs 1.97%+95%
- Market cap$385.48Bvs $100.52B+74%
- Net margin30.94%vs 13.75%+56%
SNPS leads on
- Revenue CAGR 5y13.81%vs 5.96%+57%
- Gross margin75.14%vs 49.98%+33%
- EPS CAGR 5y13.15%vs 11.27%+14%
- Debt / Equity0.3xvs 0.4x+7%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.